Sees Q2 adjusted EBITDA $7M-$9M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFMD:
- LifeMD options imply 12.4% move in share price post-earnings
- Is LFMD a Buy, Before Earnings?
- Unusually active option classes on open April 30th
- LifeMD’s Strategic Growth: Buy Rating Backed by Wegovy Integration and Future Offerings
- HIMS Stock Soars 27% as Novo Nordisk (NVO) Expands Wegovy Access to Telehealth
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue